This optimistic session for the local markets followed a mixed start to the American trading week over on Wall Street in the early hours of this morning.

The Dow Jones Industrial Average Index (DJX: .DJI) managed to snatch a win from the jaws of defeat, rising by 0.11%.

The tech-heavy Nasdaq Composite Index (NASDAQ: .IXIC) wasn't so lucky, though, falling 0.73%.

But let's return to Australian shares now and take stock of how today's indecisiveness affected the various ASX sectors this session.

The post Here are the top 10 ASX 200 shares today appeared first on The Motley Fool Australia.

Four ASX shares that are not letting that hold them back are listed below. Here's why they are rising:

4DMedical Ltd (ASX: 4DX)

The 4DMedical share price is up 3% to $6.47. This morning, the respiratory imaging technology company revealed that its CT:VQ product has received CE Mark certification for commercial use in the European Union. The company notes that this allows it to immediately commence commercial engagement with healthcare providers, which sets up a pathway for clinical adoption and collaboration with major European hospital networks. 4DMedical's CEO and founder, Andreas Fouras, said: "CE Mark certification for CT:VQ is a significant milestone that opens access to one of the world's largest and most sophisticated healthcare markets. Combined with FDA clearance, 4DMedical now holds regulatory approval to rapidly commercialise CT:VQ across both the U.S. and the EU."

Clinuvel Pharmaceuticals Ltd (ASX: CUV)

The Clinuvel Pharmaceuticals share price is up 1.5% to $9.93. This has been driven by news that the biopharmaceutical company is showcasing at America's largest dermatology conference. Clinuvel's head of North American operations, Dr Linda Teng, said: "Following the success of the 2025 AAD Meeting, our team has refined its approach to ensure maximum engagement with the dermatology community ultimately aimed at helping to treat patients with melanocortin therapies. We know there is great demand from physicians who wish to offer more to their vitiligo patients, while interest in our commercial program for EPP continues to grow as patients seek approved therapy."

Life360 Inc (ASX: 360)

The Life360 share price is up 1.5% to $19.28. This week, Bell Potter put a buy rating and $37.75 price target on its shares. This is almost double its current share price. Commenting on its expectations for the first quarter, the broker said: "After setting expectations relatively low for Q1, there is some chance of a small beat, perhaps more in the adjusted EBITDA margin rather than MAU growth."

Silex Systems Ltd (ASX: SLX)

The Silex Systems share price is up 1% to $5.34. This morning, the laser uranium enrichment technology company advised that Global Laser Enrichment (GLE) has received preliminary approval for a major US government funding package. GLE is the exclusive licensee of the Silex uranium enrichment technology. The performance-based incentives package will provide up to US$98.9 million (A$142.6 million) in tax and other economic incentives.

The post Why 4DMedical, Clinuvel, Life360, and Silex shares are pushing higher today appeared first on The Motley Fool Australia.

Shares in the company, which focuses on laser uranium enrichment technology, closed yesterday trading for $5.29. In early morning trade on Friday, Silex shares are changing hands for $5.31 apiece, up 0.4%.

For some context, the ASX 200 is down 0.6%, with the Aussie benchmark index following US markets lower as hopes for a near-term end of the Iran war fade.

Here's why Silex shares are outperforming.

ASX 200 uranium stock gets US government boost

Investors are bidding up Silex shares this morning after the company announced a major US government funding package for Global Laser Enrichment (GLE). GLE is the exclusive licensee of the Silex uranium enrichment technology.

The ASX 200 uranium stock said it has received preliminary approval on an incentives package with the Commonwealth of Kentucky and McCracken County. The funding from the state and local governments will support the development of the planned Paducah Laser Enrichment Facility (PLEF).

Silex reported that the performance-based incentives package will provide the company with up to US$98.9 million (AU$142.6 million) in tax and other economic incentives, subject to GLE reaching certain investment and job creation levels.

The PLEF is expected to be the single largest capital investment in Western Kentucky's history.

To date, the ASX 200 uranium stock noted that GLE has been backed by around US$600 million in privately funded engineering, design, manufacturing, and licensing investments across North Carolina and Kentucky.

GLE was also recently awarded up to US$28.5 million from the US Department of Energy (DOE).

Silex said that it expects the planned PLEF will "play a pivotal role" in rebuilding and strengthening the US domestic supply chain for uranium, conversion, and enrichment services.

What did management say?

Commenting on the funding package that's helping boost the ASX 200 uranium stock today, Silex CEO and managing director Michael Goldsworthy said, "We are greatly appreciative of the support for GLE's PLEF from the Commonwealth of Kentucky and McCracken County."

Goldsworthy added:

With an advanced Nuclear Regulatory Commission (NRC) licensing effort underway, ongoing focus on technology and manufacturing maturation programs and full-scale preliminary detailed design for the PLEF, we welcome the support for the PLEF from US federal, state, and local partners as we progress towards the commercial deployment of the world's first lased-based uranium enrichment plant.

With today's intraday gains factored in, shares in the ASX 200 uranium stock are up 38.9% over 12 months, racing ahead of the 6.3% one-year gains posted by the benchmark index.

The post ASX 200 uranium stock lifts off on $143 million US laser news appeared first on The Motley Fool Australia.

By the time trading wrapped up, the S&P/ASX 200 Index (ASX: XJO) had gained a pleasing 1.85%. That lifts the index up to 8,534.3 points.

This happy Wednesday for the local markets comes despite a far more bearish morning over on Wall Street.

The Dow Jones Industrial Average Index (DJX: .DJI) couldn't quite stick the landing, dropping 0.18%

The tech-heavy Nasdaq Composite Index (NASDAQ: .IXIC) fared even worse, falling by 0.84%.

But let's get back to the ASX now and dig into what was going on amongst the various ASX sectors today.

The post Here are the top 10 ASX 200 shares today appeared first on The Motley Fool Australia.

Industrials was the second-best performer among the 11 ASX 200 market sectors, rising 10.2% with total returns of 13.98%.

Let's check out the top performing ASX 200 industrial shares of the year.

5 best ASX 200 industrial shares for capital growth

These were the five best-performing shares for price growth in 2025.

1. DroneShield Ltd (ASX: DRO)

ASX 200 defence share Droneshield leapt 300% to close at $3.08 on 31 December.

That was actually a major retreat on the industrial share's 52-week high of $6.61.

Droneshield is riding the wave of increased global defence spending.

However, investors were alarmed in November when CEO Oleg Vornik sold more than $49 million worth of shares.

In response, DroneShield announced a mandatory minimum shareholding policy for all directors and senior managers. 

2. Austal Ltd (ASX: ASB)

Fellow ASX 200 defence share, Austal, increased 116% to close at $6.69 per share on 31 December.

Austal's 52-week high last year was $8.60 per share.

Austal is Australia's largest defence exporter.

Its clients include the Australian Navy and the US Navy, and it owns shipyards in the US, Australia, Vietnam, and the Philippines.

Austal announced several new contracts last year, including a $1.029 billion design and construct contract for the Australian Army.

In December, Treasurer Jim Chalmers and the Foreign Investment Review Board (FIRB) approved an application lodged by a long-time suitor for Austal to buy up to a 19.9% stake.

South Korean shipbuilder Hanwha Corp is a Fortune 500 company the offered to buy Austal for $2.825 per share in cash in 2024.

3. Monadelphous Group Ltd (ASX: MND)

The Monadelphous share price ripped 89% to close the year at $26.51. Its 52-week high was $27.83.

Monadelphous provides engineering, construction, and maintenance services in the resources, energy, and industrial sectors.

At the company's AGM in November, chair Rob Velletri said Monadelphous had secured about $2.3 billion in new contracts and extensions in FY25, which was a record, plus another $570 million since the end of the financial year.

The following month, Monadelphous announced a $250 million contract with Rio Tinto Ltd (ASX: RIO) for it Brockman Syncline 1 iron ore development.

4. Silex Systems Ltd (ASX: SLX)

The Silex Systems share price soared 71% to finish the year at $8.63.

The industrial share's annual high was $10.85 per share.

The nuclear technology developer ascended into the benchmark index in the December rebalance.

My colleague, Leigh Gant, describes Silex Systems as "one of the most fascinating energy technology stories on the ASX".

The company is working on one of the most advanced enrichment processes in the world.

Its proprietary SILEX laser system separates uranium isotopes more efficiently than traditional centrifuge methods.

The system recently gained TRL-6 validation, and could redefine how nuclear fuel is produced in the future.

5. Ventia Services Group Ltd (ASX: VNT)

The Ventia Services share price rose 65% to close 2025 at $5.95 per share. The 52-week high was $6.05.

Ventia is a leading infrastructure maintenance services provider in Australia and New Zealand.

Ventia announced several new contracts in 2025.

This included a $100 million NSW Whole‑of‑Government cleaning contract for Western Sydney, with a potential one-year extension.

During the August earnings season, Ventia reported a 19.4% lift in the value of work in hand to a record $20.6 billion for 1H FY25.

The post 5 best ASX 200 industrial shares of 2025 appeared first on The Motley Fool Australia.

Four ASX shares that are falling more than most today are listed below. Here's why they are dropping:

Andean Silver Ltd (ASX: ASL)

The Andean Silver share price is down 2.5% to $2.42. This follows news that the silver miner has doubled the size of its share purchase plan (SPP) due to increased demand. The SPP will now raise $6 million, but it could have been so much more. Andean Silver revealed that it received applications totalling approximately $18 million, which significantly exceeded the original $3 million target. Andean Silver's chair, David Southam, said: "The demand for the SPP was exceptionally strong, reflecting the rapid progress we are making at the Cerro Bayo Project and our ability to unlock an abundance of opportunities to drive growth and value creation. The proceeds from the Placement and SPP will help us accelerate our drilling programs, project studies and potential land acquisitions. Andean is uniquely placed in the silver market with its significant existing infrastructure, which will help deliver a capital-light restart in the quickest and most efficient manner."

Commonwealth Bank of Australia (ASX: CBA)

The CBA share price is down over 2% to $156.76. This is despite there being no news out of the banking giant. However, it is worth noting that all the big four banks are sharply lower today. This could be a sign that some large investors are rotating out of the banks and into other areas.

Life360 Inc (ASX: 360)

The Life360 share price is down 2.5% to $31.18. This morning, this location technology company announced the completion of its Nativo acquisition and provided an update on its user growth. With respect to the latter, Life360 now has over 50 million monthly active users (MAU) in the United States. This is up from 48.7 million at the end of September, which may be lower than the market was expecting given its historical growth rates.

Silex Systems Ltd (ASX: SLX)

The Silex Systems share price is down 35% to $6.33. This morning, the company revealed that its joint venture business, Global Laser Enrichment, has not been selected for a US$900 million program focused on low enriched uranium by the U.S. Department of Energy (DOE). And while the company has been selected for an award of up to US$28 million from the DOE to advance next generation laser-based uranium enrichment technology, this wasn't the award the market was hoping for.

The post Why Andean Silver, CBA, Life360, and Silex shares are dropping today appeared first on The Motley Fool Australia.

The company said in a statement to the ASX on Tuesday that Global Laser Enrichment, which was the exclusive licensee of its uranium enrichment technology, had been selected for an award of up to US$28 million "to advance next generation laser-based uranium enrichment technology''.

Passed over for contract

While that was a positive, the licensee company was not selected for an award under a separate US$900 million program focused on "low enriched uranium".

Silex owns a 51% stake in GLE, with major uranium producer Cameco Corporation owning the remainder.

Silex's system utilises laser technology to enrich uranium, and the company stated in a recent investor briefing that this technology is anticipated to be lower in cost than other processes, with higher efficiency and throughput.

The company has validated the process at the pilot plant scale but has not yet deployed it on a commercial scale.

Forward plan still bright

Silex said on Tuesday it was actively pursuing the next steps to advance its Paducah Laser Enrichment Facility (PLEF) in Kentucky, "and commercial deployment of its laser enrichment technology''.

The company went on to say:

The significantly higher enrichment efficiency and throughput of the Silex technology places GLE in a very strong position relative to competitors using second generation centrifuge technology.

Silex said in terms of its path forward, it intends to "re-enrich" depleted uranium tailings from the US Department of Energy at the Paducah facility.

The company said further:

This would generate up to 5 million pounds of uranium and 2,000 metric tonnes of conversion capacity annually for up to three decades – enough domestic supply to fuel around 10% of current US nuclear reactor demand. This represents a nearly ten-fold increase in domestic natural uranium output, significantly enhancing US national energy security and fuel independence.

Silex also reaffirmed its commitment to commercialising its technology, saying it was the "world's most advanced enrichment technology''.

The company added:

Subject to various factors, including industry and government support, a feasibility study for the PLEF, and supportive market conditions, the Silex uranium enrichment technology could become a major contributor to nuclear fuel production for the world's current and future nuclear reactor fleet, through the production of uranium in several different forms.

Silex shares jumped on Monday, likely in anticipation of the contract announcement, but plunged more than 29% on Tuesday morning to be changing hands for $6.93.

The company was worth $2.71 billion at the close of trade on Monday.

The post This previously hot uranium technology stock has been sold down heavily after a contract snub appeared first on The Motley Fool Australia.

Here are some ASX All Ords shares that attracted strong buy consensus ratings on the CommSec platform this month.

9 ASX All Ords shares with strong buy ratings for 2026

A consensus rating is the average rating from all analysts covering a stock.

Vault Minerals Ltd (ASX: VAU)

The Vault Minerals share price is currently $5.47, up 1% on Wednesday.

The ASX All Ords gold share has risen 154% in 2025.

Like all ASX All Ords gold stocks, Vault Minerals has benefited from the runaway gold price.

The yellow metal has ripped 66% higher in 2025 and is currently trading at US$4,354 per ounce.

UBS is among the brokers giving Vault Minerals shares a buy rating.

The broker's 12-month price target is $6.60.

Orica Ltd (ASX: ORI) 

The Orica share price is $24.34, down 0.5% on Wednesday.

The explosives manufacturer has experienced 47% share price growth in 2025.

RBC Capital Markets is one of the brokers giving this stock an outperform rating.

Its 12-month price target for Orica shares is $27.50.

Qantas Airways Ltd (ASX: QAN) 

The Qantas share price is $10.30, down 0.1%.

The market's largest ASX All Ords airline share has lifted 13% in 2025.

Here are the important dates for Qantas shareholders in the new year.

NextDC Ltd (ASX: NXT)

The NextDC share price is $12.45 on Wednesday, down 0.2%.

This ASX All Ords technology share is down 17% for 2025.

Jefferies is among the brokers backing NextDC shares for growth in 2026.

The broker's 12-month price target is $18.10.

Westgold Resources Ltd (ASX: WGX) 

The Westgold Resources share price is $6.41, up 0.5% today.

The ASX All Ords gold share has lifted 122% in 2025.

RBC Capital Markets is among the experts giving this stock a buy rating.

The broker lifted its 12-month price target from $5.80 to $7.80 this month.

Wisetech Global Ltd (ASX: WTC)

The Wisetech share price is $68.21, up 0.6% on Wednesday.

The tech sector's No.1 stock by market capitalisation has had a turbulent year.

Overall, Wisetech shares are down 45% in the year to date.

Adore Beauty Group Ltd (ASX: ABY)

Adore Beauty shares are trading at $1.24 apiece, up 2% on Wednesday.

The ASX All Ords consumer discretionary share has ripped 32% in 2025.

Cleanaway Waste Management Ltd (ASX: CWY)

The Cleanaway Waste Management share price is $2.62, up 0.2%.

The ASX All Ords industrial share is down 1% in the year to date.

Goldman Sachs is buy-rated on this stock with a price target of $3.15.

Silex Systems Ltd (ASX: SLX)

The Silex Systems share price is $8.51, up 2.4% today.

The ASX All Ords industrials share is up 67% for 2025.

The nuclear technology developer ascended into the S&P/ASX 200 Index (ASX: XJO) in the December rebalance.

Shaw & Partners is among the brokers giving this stock a buy rating.

The broker has a 12-month price target of $11.20 on Silex Systems shares.

The post 9 ASX All Ords shares upgraded to strong buy ratings for the new year appeared first on The Motley Fool Australia.

Will the market be able to build on this on Monday? Here are five things to watch:

ASX 200 expected to rise again

The Australian share market looks set for a good start to the week following a strong finish to the last one on Wall Street on Friday. According to the latest SPI futures, the ASX 200 is expected to open the day 41 points or 0.45% higher. In the United States, the Dow Jones was up 0.4%, the S&P 500 rose 0.9%, and the Nasdaq stormed 1.3% higher.

Oil prices charge higher

It could be a decent start to the week for ASX 200 energy shares Santos Ltd (ASX: STO) and Woodside Energy Group Ltd (ASX: WDS) after oil prices charged higher on Friday night. According to Bloomberg, the WTI crude oil price was up 0.9% to US$56.52 a barrel and the Brent crude oil price was up 1.1% to US$60.47 a barrel. Traders were bidding oil prices higher after Donald Trump wouldn't rule out a war with Venezuela.

Quarterly rebalance

This morning, a number of ASX 200 shares will leave the benchmark index after being kicked out at the quarterly rebalance. Leaving the index this morning are the likes of Bapcor Ltd (ASX: BAP), HMC Capital Ltd (ASX: HMC) and Corporate Travel Management Ltd (ASX: CTD). Joining the index this morning are stocks including Aussie Broadband Ltd (ASX: ABB), Resolute Mining Ltd (ASX: RSG), and Silex Systems Ltd (ASX: SLX).

Gold price rises

ASX 200 gold shares Newmont Corporation (ASX: NEM) and Northern Star Resources Ltd (ASX: NST) could have a good start to the week after the gold price pushed higher on Friday night. According to CNBC, the gold futures price was up 0.5% to US$4,387.3 an ounce. Rate cut optimism gave the gold price a boost.

Buy Boss Energy shares

Bell Potter thinks that investors should be buying Boss Energy Ltd (ASX: BOE) shares after their sell off. This morning, the broker has reaffirmed their buy rating on the uranium producer's shares with a reduced price target of $2.00 (from $2.90). It said: "Our valuation assumes production at Honeymoon over the short 10Y mine life is limited to ~1.6Mlbs pa and costs remain elevated, until such a time that management have completed the work to guide otherwise."

The post 5 things to watch on the ASX 200 on Monday appeared first on The Motley Fool Australia.

Three are gold mining stocks: Ora Banda Mining Ltd (ASX: OBM), Pantoro Gold Ltd (ASX: PNR), and Resolute Mining Ltd (ASX: RSG).

Also entering the ASX 200 are Canadian uranium miner, Nexgen Energy (Canada) CDI (ASX: NXG), telco share Aussie Broadband Ltd (ASX: ABB), and nuclear technology developer, Silex Systems Ltd (ASX: SLX).

Rebalances are important because they ensure our indices accurately rank Australia's largest companies by market capitalisation.

Joining the benchmark index is a major win for these companies.

Not only does it give them a bit of prestige and greater standing in the minds of investors, but it also forces passive institutional investment.

You see, many exchange-traded funds (ETFs) and managed funds track the performance of the ASX 200.

So at each rebalance, the fundies have to buy the stocks that join the ASX 200 and sell those that leave so their ETFs function correctly.

This often leads to extra trading activity around the ASX 200 rebalance date, which may affect a company's share price.

So, how have these about-to-be ASX 200 shares performed in 2025, and should you buy any of them?

Let's defer to the experts.

Expert ratings on newly-crowned ASX 200 shares

Ora Banda Mining shares

The Ora Banda Mining share price has risen 83% in 2025 to $1.21 at the time of writing.

Macquarie just upgraded its rating on Ora Banda shares from neutral to outperform with a 12-month price target of $1.50.

The broker said:

We still expect gold to trade at historically high levels in the near-term while also being held back by an upturn in global growth and a monetary policy easing cycle that falls short of market expectations.

MA Financial has a hold rating on this soon-to-be ASX 200 gold share with a $1.22 target.

Pantoro Gold shares

The Pantoro Gold share price has risen 194% to $4.56 in the year to date (YTD).

Tim McCormack from Canaccord Genuity has a buy rating on Pantoro Gold shares with a price target of $7.30.

Morgans maintained a trim rating on the soon-to-be ASX 200 share after its 1Q FY26 update.

The broker lowered its price target from $5.92 to $5.06, commenting:

PNR delivered a softer-than-expected operating result for 1Q, even relative to our already conservative expectations despite record gold prices.

A series of isolated operating issues and underground mine sequencing drove lower head-grade and thus lower ounce production and higher unit costs.

PNR has reiterated its FY26 guidance.

Resolute Mining shares

The Resolute Mining share price has risen 159% to $1.06 per share on Tuesday.

Macquarie gives Resolute Mining shares an outperform rating with a price target of $1.35.

The broker said:

Execution of the Syama expansion project remains key to our outlook for RSG in Mali.

Delivery of the Doropo feasibility study and positive progress towards development is also key longer term.

RSG continues to be exposed to geopolitical risk in Mali due to recent actions by the government.

Canaccord Genuity also has a buy rating on this soon-to-be ASX 200 gold share with a 12-month target of $2.

Nexgen Energy shares

The Nexgen Energy share price has risen 30% in 2025 to $14.03 today.

Shaw & Partners has a buy rating on this soon-to-be ASX 200 energy share with a price target of $17.70.

Petra Capital is also optimistic with a buy rating and a target of $17.14.

Bell Potter gives Nexgen shares a hold rating with a price target of $13.05.

Aussie Broadband shares

The Aussie Broadband share price has risen 43% in the YTD to $5.05 today.

Macquarie recently downgraded Aussie Broadband shares to a neutral rating with a price target of $5.10.

Jarden gives this soon-to-be ASX 200 telco share a buy rating with a target of $5.80.

Canaccord Genuity is also positive on Aussie Broadband shares. It has a buy rating and a target of $6.85.

Silex Systems shares

The Silex Systems share price has risen 66% in 2025 to $8.47 today.

My colleague, Leigh Gant, describes Silex Systems as "one of the most fascinating energy technology stories on the ASX".

Canaccord Genuity has a buy rating with a target of $9.42 on this soon-to-be ASX 200 industrials share.

Shaw & Partners also has a buy rating with a 12-month price target of $11.20.

The post Broker ratings on 6 ASX shares about to join the ASX 200 appeared first on The Motley Fool Australia.

S&P Dow Jones Indices announced its December quarter rebalance after the market closed on Friday.

Of the six companies joining the index, four are miners.

The others are fellow gold miners Pantoro Gold Ltd (ASX: PNR) and Resolute Mining Ltd (ASX: RSG), and Canadian uranium miner, Nexgen Energy Ltd (ASX: NXG).

Telecommunications share Aussie Broadband Ltd (ASX: ABB) will also ascend into the ASX 200 index.

Another business joining the ranks of Australia's top 200 listed companies is nuclear technology developer, Silex Systems Ltd (ASX: SLX).

What is an index rebalance?

The S&P Dow Jones Indices team reviews Australia's leading indices every quarter.

Rebalances ensure our indices accurately rank Australia's largest companies by market capitalisation.

Indices are important because they enable us to monitor and measure the market's performance.

The ASX 200 is the benchmark index for the Australian share market.

But other indices, like the S&P/ASX All Ordinaries Index (ASX: XAO) and S&P/ASX 300 Index (ASX: XKO), are also very important.

What does getting into the ASX 200 mean for a stock?

Gaining entry into the ASX 200 is a clear sign that a company is doing well and investors have confidence in its future.

Companies have to meet market capitalisation and liquidity requirements to make it into the ASX 200.

Getting into the ASX 200 can have a direct impact on the share price because it triggers a lot of passive investment.

Many exchange-traded funds (ETFs) and managed funds are designed to track the performance of the ASX 200.

This necessitates buying stocks when they enter the ASX 200, and selling stocks that are removed every quarter.

This often leads to extra trading activity around the rebalance date, which may influence a share's price.

Rebalances matter more than ever due to the growing number of Australians preferring to invest in ETFs over individual shares.

The latest Betashares data shows Australians invested a record $5.99 billion into ASX ETFs in October.

A record $321.7 billion in funds are invested across more than 400 ETFs on the market today.

ASX ETFs are a form of passive, diversified investment that many investors perceive as lower risk.

They are a basket of shares that investors can buy in one trade for a single brokerage fee, with low ongoing management fees thereafter.

This next rebalance will become effective on 22 December.

The post 6 ASX shares including Ora Banda and Aussie Broadband ascend into ASX 200 appeared first on The Motley Fool Australia.

Governments from the United States to Japan are extending the life of existing nuclear reactors and fast-tracking approvals for new designs, including small modular reactors. Even in Europe, where sentiment was once mixed, policy is shifting toward nuclear as a reliable, low-carbon alternative to coal and gas.

The result: uranium prices have more than doubled since 2020, reaching levels not seen in over a decade. That surge is attracting investor attention, and the ASX is emerging as a key hunting ground for exposure to this renewed "nuclear decade".

The energy transition meets the data age

Beyond climate policy, a new driver is emerging. The rapid expansion of AI infrastructure, data centres, and electrified industry is fuelling a global race for dependable power.

Unlike solar or wind, nuclear plants can provide continuous baseload generation — the type of steady electricity needed to run AI servers and industrial grids 24/7. According to VanEck, this reality underpins the thesis behind its newly listed VanEck Uranium and Energy Innovation ETF (ASX: URAN).

The ETF offers diversified exposure to global uranium miners and nuclear technology companies. It aims to capture both rising uranium demand and investment in advanced reactor designs. For Australian investors, it provides a simple, low-maintenance entry point into a sector that can otherwise be volatile and concentrated.

Paladin Energy: Producer advantage

For those who prefer individual stocks, Paladin Energy Ltd (ASX: PDN) remains one of the ASX's clearest plays on physical uranium production.

The company is restarting its flagship Langer Heinrich mine in Namibia after a five-year pause, positioning to deliver roughly 4% of global supply once fully operational. With prices now well above the levels that forced earlier shutdowns, Paladin could benefit from operating leverage as production scales.

While short-term swings in commodity prices are always a risk, Paladin's established infrastructure and offtake partnerships provide a solid foundation in a tightening market.

Silex Systems: Innovation at the core

On the technology front, Silex Systems Ltd (ASX: SLX) is pursuing one of the most advanced enrichment processes in the world.

Its proprietary SILEX laser system separates uranium isotopes more efficiently than traditional centrifuge methods — a breakthrough that recently achieved TRL-6 validation, proving the process at pilot scale. Through its 51% stake in US-based Global Laser Enrichment, Silex is working toward commercial deployment supported by growing US government interest in domestic fuel production.

It's still early days, but Silex's laser platform could redefine how nuclear fuel is produced, adding a high-tech dimension to Australia's role in the nuclear supply chain.

Why uranium's story still matters

According to the World Nuclear Association, over 60 reactors are currently under construction globally, with hundreds more planned or proposed. Existing utilities are also extending reactor lifespans to maintain energy security while meeting net-zero targets.

On the supply side, disruptions in key producing regions like Kazakhstan have tightened the market, while new projects take years to bring online. This structural gap between supply and demand is precisely what fuels bull markets in resources and why investors are paying closer attention to the uranium trade again.

Foolish Takeaway

After years in the shadows, uranium is once again in the spotlight as the world seeks scalable, carbon-free energy. ETFs, such as URAN, provide broad exposure to the global nuclear cycle. At the same time, individual names like Paladin Energy and Silex Systems highlight the breadth of opportunities on the ASX, ranging from production to innovation.

As always, uranium remains a cyclical commodity, and prices can be volatile. But for long-term investors who believe nuclear will play a larger role in powering both the planet and the digital economy, the sector's next chapter may just be beginning.

The post Why uranium is back on the radar and 3 ASX energy shares in the spotlight appeared first on The Motley Fool Australia.

At the time of writing, the share price is up more than 100% in 12 months. The uranium enrichment company has captured investors' attention amid renewed interest in nuclear power and energy independence.

The combination of strategic relevance, technological validation, and geopolitical urgency has positioned Silex as one of the ASX's standout energy innovators.

What Silex does

Silex is developing its SILEX laser uranium enrichment process, a third-generation technology designed to produce nuclear fuel more efficiently than traditional centrifuge methods.

The breakthrough lies in its ability to separate uranium isotopes using lasers, potentially lowering costs, improving safety, and reducing waste compared to existing enrichment processes.

Silex owns a 51% stake in US-based Global Laser Enrichment (GLE) — its exclusive commercialisation partner, with Canadian uranium giant Cameco holding the other 49%. Together, they're developing the Paducah Laser Enrichment Facility (PLEF) in Kentucky, which could become the only uranium enrichment plant operating in the US once commercialised.

Why the share price has been powering higher

This year's rally has been fuelled by a series of breakthroughs that have electrified the company's outlook.

• Major technical milestone: In October, an independent review verified that Silex's laser enrichment system had achieved TRL-6, proving it can operate at pilot scale in a relevant environment — the final step before pre-commercial production.
  
• US momentum: The GLE venture is bidding for up to US$900 million in Department of Energy funding under programs aimed at rebuilding domestic nuclear fuel capacity and reducing reliance on Russian supply.
  
• Secured site and licensing progress: GLE has acquired a 700-acre site in Paducah, Kentucky, with US Nuclear Regulatory Commission (NRC) licence review now underway. The aim is to begin initial commercial operations by 2030.
  
• Sector tailwinds: Global uranium prices have nearly doubled since 2022, and policy support for nuclear energy is accelerating under "net-zero" commitments and the US Prohibiting Russian Uranium Imports Act.

What's next

The company is now focused on completing the large-scale pilot demonstration and advancing feasibility work for full commercial deployment of its technology.

Silex stands to benefit from two distinct revenue streams once commercialisation occurs — a perpetual royalty on GLE's enrichment revenues and potential equity distributions from its stake in the venture.

Beyond uranium, Silex is also progressing two smaller but promising projects:

• The Quantum Silicon (Q-Si) initiative with UNSW Sydney and Silicon Quantum Computing, which aims to produce ultra-pure silicon-28 for the emerging quantum computing industry.
  
• The Medical Isotope Separation Technology (MIST) project, developing new processes for cancer-targeted radiotherapy isotopes such as lutetium-177.
  

Both projects have attracted Australian Government and partner funding, adding depth and optionality to Silex's technology platform.

Foolish Takeaway

Silex Systems is emerging as one of the most fascinating energy technology stories on the ASX.

While Silex is no longer purely pre-revenue, it remains early in the commercialisation phase. The path from pilot demonstration to production is capital-intensive and subject to regulatory, political, and market risks.

With its laser enrichment process validated at pilot scale and growing government backing, the company is moving closer to real commercial relevance after decades of research.

The share price may have already captured some of that future potential, but if Silex continues to convert milestones into momentum, its rise could still have power left in the tank.

The post This ASX uranium stock just doubled as the nuclear energy story heats up appeared first on The Motley Fool Australia.

Four ASX shares that are not letting that hold them back today are listed below. Here's why they are rising:

Australian Clinical Labs Ltd (ASX: ACL)

The Australian Clinical Labs share price is up 6% to $2.69. Investors have been buying this pathology diagnostics company's shares following the announcement of an on-market share buyback ahead of its annual general meeting. Australian Clinical Labs will buy back up to 19.5 million shares, representing approximately 10% of its outstanding share capital. It stated: "The Board believes that a share buy-back program provides an opportunity to enhance value for ACL shareholders, without compromising the company's strong balance sheet, whilst also delivering accretive investment opportunities."

Karoon Energy Ltd (ASX: KAR)

The Karoon Energy share price is up 6% to $1.52. This morning, this energy producer released its third quarter update and revealed production of 2.59MMboe. This was down 12% quarter on quarter due to issues with two Bauna Project wells and a scheduled shutdown of the Who Dat facility. Nevertheless, sales revenue increased 3% quarter on quarter to $164.1 million. Karoon Energy's CEO, Dr Julian Fowles, said: "Despite 12% lower production, sales volumes declined just 3%, reflecting Bauna cargo timings in 2Q25 and 3Q25, while 3Q25 sales revenue rose 3% to US$164.1 million, largely due to higher average Baúna realised oil prices."

MA Financial Group Ltd (ASX: MAF)

The MA Financial share price is up 9% to $9.83. This has been driven by the release of the asset manager's third quarter update. MA Financial revealed that its assets under management (AUM) grew to $13.3 billion at the end of September. This is up from $9.9 billion a year earlier. This reflects record gross fund inflows of $2.2 billion (ex. institutional) for the nine months to 30 September 2025.

Silex Systems Ltd (ASX: SLX)

The Silex Systems share price is up 12% to $8.69. This morning, this uranium enrichment technology company revealed that an independent review confirmed that its technology has achieved Technology Readiness Level 6 (TRL-6). Silex's CEO, Michael Goldsworthy, said: "We are thrilled to receive the independent assessment and validation that the SILEX laser-based uranium enrichment technology has achieved TRL-6, marking a major de-risking milestone in the commercialisation program for the SILEX technology."

The post Why Australian Clinical Labs, Karoon Energy, MA Financial, and Silex shares are roaring higher today appeared first on The Motley Fool Australia.

Namibia-focused miner Paladin Energy Ltd (ASX: PDN) has surged by 28% over the past month, whilst fellow producer Boss Energy Ltd (ASX: BOE) has delivered a 19% lift.

And the rally hasn't stopped there.

Amongst the developers, Deep Yellow Ltd (ASX: DYL) has climbed by 40% and Bannerman Energy Ltd (ASX: BMN) has served up a 49% gain.

But the standout performer is not your typical ASX uranium stock.

Silex Systems Ltd (ASX: SLX) is pioneering its cutting-edge technology designed to enrich uranium and an update on Wednesday sent its share price soaring.

All up, Silex shares have now rocketed by 64% in the past month to $5.77 per share at Friday's close.

Let's take a closer look at what makes this one-of-a-kind ASX uranium stock so compelling.

The nuclear fuel cycle

Nuclear energy is among the cleanest sources of electricity due to its minimal carbon emissions. And uranium is the critical fuel that powers it.

Uranium's journey from extraction to energy generation follows the nuclear fuel cycle.

In essence, the final product generated by mining companies is a uranium oxide concentrate typically known as yellowcake, which is then sold to utility companies.

But yellowcake is only part of the equation.

It needs to be converted and enriched prior to fabrication of the nuclear fuel used for power generation.

So, utility companies still need to secure contracts with third-party providers for these highly specialised services.

However, this can be problematic in a world of geopolitical uncertainty.

According to some estimates, 40% of global uranium enrichment takes place in Russia with another 17% in China.

And western nations with established nuclear power programs often depend on overseas suppliers for their enriched uranium.

For instance, the US imported about 72% of its enriched uranium in 2023, including 27% from Russia.

Silex is working to transform this uncertain dynamic with its cutting-edge enrichment technology.

Tell me more

In essence, the ASX uranium stock seeks to commercialise its SILEX laser-based uranium enrichment technology in the US.

This technology is being advanced through Global Laser Enrichment (GLE) – a joint venture with Cameco Corp (NYSE: CCJ) that holds the exclusive licence for SILEX.

And just last week, GLE completed large-scale enrichment demonstration testing in the US state of North Carolina.

Management noted that the testing provided confidence for potential commercial deployment of GLE's proprietary uranium enrichment process.

The program will now continue throughout 2025 with plans to produce hundreds of kilograms of low-enriched uranium.

The joint venture also seeks to establish a US manufacturing base and supply chain to support uranium enrichment in the nation.

Its planned Paducah Laser Enrichment Facility (PLEF) in Kentucky is the only new enrichment facility under licence application review by the US Nuclear Regulatory Commission.

If approved, PLEF could potentially offer a single-site solution for domestic production, conversion, and enrichment of uranium.

To date, more than US$550 million has been invested in the commercialisation push for SILEX across North Carolina and Kentucky.

The post Up 64% in a month! This unique ASX uranium stock is leading the charge amidst sector-wide rally appeared first on The Motley Fool Australia.

Four ASX shares that are not letting that hold them back are listed below. Here's why they are rising:

DroneShield Ltd (ASX: DRO)

The DroneShield share price is up a further 3% to $3.29. Investors have been buying this counter drone technology company's shares this week after it released a sales update. DroneShield has surpassed 4,000 systems sold worldwide. This follows the receipt of a package of two standalone contracts totalling $7.9 million for handheld systems for delivery to the U.S. Department of Defense. Commenting on the news, DroneShield's US CEO, Matt McCrann, said: "Passing 4,000 systems in service is an important milestone for our team and our customers. It underlines the performance and dependability of our solutions in the field, and the trust placed in DroneShield by those who rely on them."

Imricor Medical Systems Inc (ASX: IMR)

The Imricor Medical Systems share price is up 8% to $1.52. This morning, this medical device company revealed that it has successfully completed its Human Factors (HF) study covering all devices that are currently under review by the U.S. FDA. Imricor's chair and CEO, Steve Wedan, commented: "The scale of this study cannot be overstated, having taken our team over a year from planning through execution. Completing human factors testing across our entire product portfolio is an extraordinary achievement and a clear demonstration of the strength and dedication of the Imricor team. It also marks a major milestone on our path to FDA approval and positions us strongly as we prepare to bring MRI-guided ablation to the United States."

Paladin Energy Ltd (ASX: PDN)

The Paladin Energy share price is up 6% to $8.22. This uranium stock has been charging higher this week amid positive industry news. This includes the US Energy Secretary Chris Wright revealing that his government hopes to see "rapid growth" in consumption of the nuclear fuel, and that the US needed to move away from reliance on Russian-enriched uranium. In addition, the International Atomic Energy Agency (IAEA) upgraded its global nuclear operational capacity estimates.

Silex Systems Ltd (ASX: SLX)

The Silex Systems share price is up a further 16% to $5.57. Investors have been buying this uranium technology company's shares this week after a big update. Silex advised that Global Laser Enrichment (GLE), the exclusive licensee of the SILEX uranium enrichment technology, has completed the large-scale enrichment demonstration testing campaign at its Test Loop facility in North Carolina. The release reveals that GLE has collected extensive performance data providing confidence that its laser-based uranium enrichment process will achieve TRL-6 demonstration status and can be commercially deployed.

The post Why DroneShield, Imricor, Paladin Energy, and Silex shares are pushing higher appeared first on The Motley Fool Australia.

In afternoon trade, the ASX uranium stock is up 16% to $4.90.

Why is this ASX uranium stock outperforming?

Investors have been fighting to get hold of the heavily shorted uranium technology company's shares today following the release of a very positive update.

According to the release, Global Laser Enrichment (GLE), which is the exclusive licensee of the SILEX uranium enrichment technology, has completed the large-scale enrichment demonstration testing campaign at its Test Loop facility in Wilmington, North Carolina.

The good news for shareholders is that GLE has collected extensive performance data, which provides confidence that its laser-based uranium enrichment process will achieve TRL-6 demonstration status and can be commercially deployed.

This is particularly positive as short sellers appear to have been betting on the technology failing to live up to expectations. Given this announcement, it wouldn't be a surprise if they are now buying back shares to close positions and causing a short squeeze.

What's next?

The ASX uranium stock advised that GLE will continue its demonstration program through the course of 2025, producing hundreds of kilograms of Low Enriched Uranium (LEU). It will also continue towards building a US domestic manufacturing base and supply chain to support the deployment of US domestic enrichment capacity.

It notes that the results of the large-scale demonstration are subject to assessment by an independent engineering contractor. However, GLE is expecting to receive the completed TRL6 assessment report by the end of the year.

Subject to various factors, management believes the SILEX uranium enrichment technology could become a major contributor to nuclear fuel production for the world's current and future nuclear reactor fleet. This is through the production of uranium in several different forms, including natural grade uranium as UF6, LEU and LEU+, and high-assay LEU (HALEU) for next-generation advanced reactors, including small modular reactors.

Commenting on the news, the ASX uranium stock's CEO and managing director, Michael Goldsworthy, said:

This is an important milestone for GLE, which is the only company in the world to be operating large-scale, third-generation laser-based enrichment technology under plant-like conditions, that is, at TRL-6 status. We commend the efforts of the GLE and Silex teams, who have worked tirelessly to advance the SILEX uranium enrichment technology much closer to commercial readiness. This is an exciting time for Silex and GLE, and we look forward to receiving the independent assessment report later this year.

The post Guess which ASX uranium stock is surging 16% higher today appeared first on The Motley Fool Australia.

Four ASX shares that are not letting that hold them back are listed below. Here's why they are rising:

DroneShield Ltd (ASX: DRO)

The DroneShield share price is up 2% to $3.20. Investors have been buying this counter drone technology company's shares following the release of a sales update. DroneShield revealed that it has surpassed 4,000 systems sold worldwide with the receipt of a package of two standalone contracts totalling $7.9 million for handheld systems for delivery to the U.S. Department of Defense. The company expects to deliver all equipment in the fourth quarter of 2025. DroneShield's US CEO, Matt McCrann, commented: "Passing 4,000 systems in service is an important milestone for our team and our customers. It underlines the performance and dependability of our solutions in the field, and the trust placed in DroneShield by those who rely on them."

EBR Systems Inc (ASX: EBR)

The EBR Systems share price is up 11% to $1.30. This morning, this medical device company revealed that it has passed the tenth commercial implant of its WiSE System in the United States. This technology has been developed to eliminate the need for cardiac pacing leads, which are historically the major source of complications, effectiveness, and reliability issues in cardiac rhythm disease management. The company's president and CEO, John McCutcheon, said: 'Passing the ten-case milestone so soon after FDA approval reflects strong clinical interest in leadless left-ventricular endocardial pacing and underscores the value EBR's novel WiSE System brings for patients who are not well served by conventional CRT."

Silex Systems Ltd (ASX: SLX)

The Silex Systems share price is up 15% to $4.87. This follows the release of an update from the uranium technology company. It advised that Global Laser Enrichment (GLE), the exclusive licensee of the SILEX uranium enrichment technology, has completed the large-scale enrichment demonstration testing campaign at its Test Loop facility in North Carolina. The good news is that GLE has collected extensive performance data providing confidence that its laser-based uranium enrichment process will achieve TRL-6 demonstration status and can be commercially deployed.

Sunrise Energy Metals Ltd (ASX: SRL)

The Sunrise Energy Metals share price is up a further 15% to $5.02. This scandium developer's shares have been rocketing this week following a big announcement. Sunrise Energy Metals advised that it has received a letter of interest from the Export-Import Bank of the United States (EXIM) which outlines the potential to provide up to US$67 million in debt financing for the Syerston Scandium Project in central New South Wales. Management notes that based on its current estimates in the Feasibility Study, this represents approximately half the development capital for the project.

The post Why DroneShield, EBR, Silex, and Sunrise Energy Metals shares are storming higher appeared first on The Motley Fool Australia.

This is because I believe it is well worth keeping a close eye on short interest levels as high levels can sometimes be a sign that something isn't quite right with a company.

With that in mind, here are the 10 most shorted shares on the ASX this week according to ASIC:

• Boss Energy Ltd (ASX: BOE) continues to be the most shorted ASX share with short interest of 21.8%. This is down week on week. This uranium producer disappointed the market recently with guidance for FY 2026 that fell well short of expectations.
• Paladin Energy Ltd (ASX: PDN) is another uranium producer that short sellers are targeting. It has short interest of 18.3%, which is down slightly week on week. There may be concerns over the ramp up of its Langer Heinrich Mine.
• Pilbara Minerals Ltd (ASX: PLS) has seen its short interest remain rise to 15.5%. Short sellers don't appear to believe that lithium prices will be rising meaningfully in the near term.
• IDP Education Ltd (ASX: IEL) has 14.2% of its shares held short, which is up week on week again. Short sellers will have been disappointed to see this language testing and student placement company's shares rocket last week after it released its results.
• Polynovo Ltd (ASX: PNV) has 12% of its shares held short, which is up week on week once again. Valuation concerns could be the reason why short sellers are targeting this medical device company's shares.
• Mineral Resources Ltd (ASX: MIN) has short interest of 11.8%, which is up week on week. This mining and mining services company has a precarious balance sheet and is exposed to weak commodity prices.
• Lifestyle Communities Ltd (ASX: LIC) has seen its short interest remain flat at 11.5%. This retirement living company has been battling tough trading conditions. These have been caused by negative media coverage. It also lost a major court battle recently.
• Corporate Travel Management Ltd (ASX: CTD) has short interest of 9.8%, which is flat week on week. This corporate travel specialist's shares have been suspended for a week after becoming "aware that a material correction will need to be made to certain aspects of the Company's previous financial statements."
• PWR Holdings Ltd (ASX: PWH) has entered the top ten with short interest of 9.5%. This motorsport products company's shares tumbled last week after disappointing with its full year results. Another transition year is expected in FY 2026, which also appears to have put pressure on its shares.
• Silex Systems Ltd (ASX: SLX) has seen its short interest rise to 9%. There may be doubts over this uranium enrichment technology company's pivotal TRL-6 demonstration later this year.

The post These are the 10 most shorted ASX shares appeared first on The Motley Fool Australia.

This is because I believe it is well worth keeping a close eye on short interest levels as high levels can sometimes be a sign that something isn't quite right with a company.

With that in mind, here are the 10 most shorted shares on the ASX this week according to ASIC:

• Boss Energy Ltd (ASX: BOE) continues to be the most shorted ASX share after its short interest climbed to 22.8%. This uranium producer's shares have been under significant pressure since its guidance for FY 2026 fell materially short of expectations.
• Paladin Energy Ltd (ASX: PDN) has seen its short interest rise again to 18.5%. Concerns over the ramp up of the uranium miner's Langer Heinrich Mine could be behind this.
• Pilbara Minerals Ltd (ASX: PLS) has seen its short interest remain flat at 15.1%. While lithium prices have rebounded recently, short sellers seem to believe that this will be short-lived.
• IDP Education Ltd (ASX: IEL) has 14.1% of its shares held short, which is up week on week. Later this week, this language testing and student placement company is releasing its results and is expected to post a sharp decline in profits.
• Polynovo Ltd (ASX: PNV) has 11.6% of its shares held short, which is up week on week again. Short sellers appear to believe that this medical device company's shares are overvalued at current levels. Its results are due to be released today.
• Lifestyle Communities Ltd (ASX: LIC) has seen its short interest ease slightly to 11.5%. This retirement living company has been battling tough trading conditions caused by negative media coverage and lost a major court battle.
• Mineral Resources Ltd (ASX: MIN) has short interest of 11.5%, which is down week on week again. There are concerns over the state of the miner's balance sheet and its exposure to weak commodity prices.
• Corporate Travel Management Ltd (ASX: CTD) has short interest of 9.8%, which is down week on week. This corporate travel specialist suspended its shares last week after becoming "aware that a material correction will need to be made to certain aspects of the Company's previous financial statements."
• Silex Systems Ltd (ASX: SLX) has seen its short interest tumble to 8.9%. This uranium enrichment technology company recently raised $130 million through a capital raising. Short sellers may have used this as an opportunity to buy shares to close positions.
• Cettire Ltd (ASX: CTT) has returned to the top ten with short interest of 8.7%. This online luxury products retailer has been hit hard by a downturn in the industry and import tax changes in the US. So much so, some short sellers appear to believe its business model is now broken.

The post These are the 10 most shorted ASX shares appeared first on The Motley Fool Australia.